Desenvolvimento e avaliação da atividade antitumoral in vitro de paclitaxel associado a magnetossomas por magnetohipertermia
Αποθηκεύτηκε σε:
| Κύριος συγγραφέας: | |
|---|---|
| Ημερομηνία έκδοσης: | 2018 |
| Μορφή: | Doctoral thesis |
| Γλώσσα: | por |
| Πηγή: | Repositório Institucional da UFG |
| Download full: | http://repositorio.bc.ufg.br/tede/handle/tede/11160 |
Περίληψη: | This work describes the development and characterization of Magnetosomes Paclitaxel loaded (MS PTX-loaded) for cutaneous applications in magnetohyperthermia. Magnetic nanoparticles (MP) were prepared by coprecipitation of Fe (II) and Fe (III) or Mn (II) and Fe (III) salts in alkaline medium. MS were produced by hydration method of a preformed lipid film. The nanostructured system was characterized in terms of morphology, mean diameter and size distribution, encapsulation efficiency of PTX, stability and magnetic properties of magnetometry and magnetohyperthermia. MS PTX-loading had an average diameter of approximately 90nm with polydispersion index of 0.190. The PTX: lipid ratio was 1:50 (m/m) with 81% PTX encapsulation efficiency. Stability study of lyophilized MS PTX-loading showed 98% of the encapsulation efficiency for 60 days. MS PTX-loading presented superparamagnetic behavior in the presence of magnetic field, with saturation magnetization of 0.25 emu/g and volumetric fraction of 11.3x10-3. The concentration of MP in the formulation was 5.56mg/mL. The effect of magnetohyperthermia with variation of temperature of up to 30ºC was verified from the application of alternating magnetic field. This increase in MS temperature influenced the rate of in vitro release of the encapsulated PTX, allowing an increase of 400% release comparing temperatures of 25ºC and 43ºC. Thus, through the in vitro release study it was possible to perceive that magnetohyperthermia could act as a release trigger of PTX encapsulated in MS. From the biological assay of cytotoxicity with B16F10 cells it was possible to verify the cellular viability of the nanosystem and to determine the IC50. The application of a magnetic field together with the release of PTX showed a great potential for the cytotoxic action under the B16F10 strain by the impossibility of approximately 100% of the cells in a period of 1.5h. |
Παρόμοια τεκμήρια: Desenvolvimento e avaliação da atividade antitumoral in vitro de paclitaxel associado a magnetossomas por magnetohipertermia
- Sistemas nanoestruturados multicompartimentais para coencapsulação e liberação controlada de paclitaxel e genisteína: desenvolvimento, caracterização e avaliação da atividade antitumoral in vivo
- Desenvolvimento, caracterização e estudo de liberação in vitro por magnetohipertermia de paclitaxel em nanopartículas lipídicas sólidas magnéticas
- Desenvolvimento, caracterização e avaliação da atividade antiproliferativa de paclitaxel e rapamicina em lipossomas alvo-específicos contra células de câncer de mama HER2-positivas
- Imitadores sintéticos de miR-7 E miR-34a associados ao paclitaxel na terapia experimental in vitro de câncer de mama
- Desenvolvimento de sistemas lipídicos nanoestruturados contendo paclitaxel: estudos de permeação cutânea
- Desenvolvimento e validação de metodologia bioanalítica e sua aplicação para a determinação da farmacocinética e biodistribuição do paclitaxel e genisteína co-encapsulados em nanopartículas multicompartimentais